Abstract:The splicing regulator Polypyrimidine Tract Binding Protein (PTBP1) has four RNA binding domains that each binds a short pyrimidine element, allowing recognition of diverse pyrimidine-rich sequences. This variation makes it difficult to evaluate PTBP1 binding to particular sites based on sequence alone and thus to identify target RNAs. Conversely, transcriptome-wide binding assays such as CLIP identify many in vivo targets, but do not provide a quantitative assessment of binding and are informative only for the cells where the analysis is performed. A general method of predicting PTBP1 binding and possible targets in any cell type is needed. We developed computational models that predict the binding and splicing targets of PTBP1. A Hidden Markov Model (HMM), trained on CLIP-seq data, was used to score probable PTBP1 binding sites. Scores from this model are highly correlated (rho = -0.9) with experimentally determined dissociation constants. Notably, we find that the protein is not strictly pyrimidine specific, as interspersed Guanosine residues are well tolerated within PTBP1 binding sites. This model identifies many previously unrecognized PTBP1 binding sites, and can score PTBP1 binding across the transcriptome in the absence of CLIP data. Using this model to examine the placement of PTBP1 binding sites in controlling splicing, we trained a multinomial logistic model on sets of PTBP1 regulated and unregulated exons. Applying this model to rank exons across the mouse transcriptome identifies known PTBP1 targets and many new exons that were confirmed as PTBP1-repressed by RT-PCR and RNA-seq after PTBP1 depletion. We find that PTBP1 dependent exons are diverse in structure and do not all fit previous descriptions of the placement of PTBP1 binding sites. Our study uncovers new features of RNA recognition and splicing regulation by PTBP1. This approach can be applied to other multi-RRM domain proteins to assess binding site degeneracy and multifactorial splicing regulation.

Polypyrimidine Track-binding Protein Binding Downstream of Caspase-2 Alternative Exon 9 Represses Its Inclusion*

Caspase-2 Pre-Mrna Alternative Splicing: Identification of an Intronic Element Containing A Decoy 3 ' Acceptor Site

An intronic signal for alternative splicing in the human genome.

Genome-wide Analysis of PTB-RNA Interactions Reveals a Strategy Used by the General Splicing Repressor to Modulate Exon Inclusion or Skipping

Regulation of BCL-X splicing reveals a role for the polypyrimidine tract binding protein (PTBP1/hnRNP I) in alternative 5′ splice site selection

Up-regulation of the Proapoptotic Caspase 2 Splicing Isoform by a Candidate Tumor Suppressor, RBM5.

Positioning of pyrimidine motifs around cassette exons defines their PTB-dependent splicing in Arabidopsis

Identification and Characterization of a Minimal Functional Splicing Regulatory Protein, PTBP1

Polypyrimidine tract binding proteins PTBP1 and PTBP2 interact with distinct proteins under splicing conditions

A Pathway Involving HDAC5, Cflip and Caspases Regulates Expression of the Splicing Regulator Polypyrimidine Tract Binding Protein in the Heart.

KIS counteracts PTBP2 and regulates alternative exon usage in neurons

De Novo Prediction of PTBP1 Binding and Splicing Targets Reveals Unexpected Features of Its RNA Recognition and Function

Topoisomerase I and II Inhibitors Control Caspase-2 Pre-Messenger RNA Splicing in Human Cells

An ancient competition for the conserved branchpoint sequence influences physiological and evolutionary outcomes in splicing

PSF Suppresses Tau Exon 10 Inclusion by Interacting with a Stem-Loop Structure Downstream of Exon 10.

Srp54 (sfrs11), A Regulator for Tau Exon 10 Alternative Splicing Identified by an Expression Cloning Strategy

Interplay between splicing and transcriptional pausing exerts genome-wide control over alternative polyadenylation

The Alternative Splicing of Intersectin 1 Regulated by PTBP1 Promotes Human Glioma Progression.

Study on the Regulating Mechanism of PTB in Alternating Splicing of Tumor Suppressor Gene Ceacam1 in Non-Small Cell Lung Cancers

PTBP1 and PTBP2 Impaired Autoregulation of SRSF3 in Cancer Cells

Modulation of PDCD1 Exon 3 Splicing